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Abstract
Background: Early discharge of healthy late preterm and full term newborn infants has become common practice
because of the current social and economic necessities. Severe jaundice, and even kernicterus, has developed in
some term infants discharged early. This study was designed to elaborate a percentile-based hour specific total
serum bilirubin (TSB) nomogram and to assess its ability to predict the absence of risk for subsequent non
physiologic severe hyperbilirubinaemia before discharge.
Methods: A percentile-based hour-specific nomogram for TSB values was performed using TSB data of 1708
healthy full term neonates. The nomogram’s predictive ability was then prospectively assessed in five different first
level neonatal units, using a single TSB value determined before discharge.
Results: The 75
th percentile of hour specific TSB nomogram allows to predict newborn babies without significant
hyperbilirubinemia only after the first 72 hours of life. In the first 48 hours of life the observation of false negative
results did not permit a safe discharge from the hospital.
Conclusion: The hour-specific TSB nomogram is able to predict all neonates without risk of non physiologic
hyperbilirubinemia only after 48 to 72 hours of life. The combination of TSB determination and risk factors for
hyperbilirubinemia could facilitate a safe discharge from the hospital and a targeted intervention and follow-up.
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Background
Early discharge of healthy late preterm and full term
newborn infants has become common practice because
of the current social and economic necessities [1-3].
The association between early discharge and the
need for readmission has been frequently reported,
mainly because of unexpected severe hyperbilirubine-
mia [1,4,5].
In fact, severe jaundice and even kernicterus has
developed in some term infants discharged early [6-8].
For these reasons the detection of infants without risk
of severe hyperbilirubinemia has become one of the
most intriguing challenges for neonatologists. However,
the ability of physicians and other health care providers
to recognize clinically significant jaundice and predict
bilirubin levels based on the cephalocaudal progression
of jaundice is limited [9-12]. Total serum bilirubin
(TSB) or Transcutaneous bilirubin (TcB) determination
is often the only way to avoid such difficulty but the
reliability of a single TSB/TcB value to identify newborn
infants at risk of significant hyperbilirubinemia is not
univocally accepted [13-18]. Moreover, some authors
suggested caution in applying hour-specific nomograms
elaborated on different newborn population [19]. In this
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fic TSB nomogram in healthy full term neonates in the
first four days of life and to verify its clinical reliability
in a prospective multicenter study involving five neona-
tal units of our region in order to identify infants with-
out risk for subsequent severe hyperbilirubinemia and to
achieve a safe neonatal discharge.
Materials and methods
The study was conducted in 2 phases. In phase one
1708 healthy full term infants were studied to assess the
normal neonatal trend of TSB with the aim to elaborate
the percentile-based hour specific nomogram. In phase
two, the predictive ability of the nomogram was assessed
in a large study population from five different neonatal
units of our region.
Phase one - Elaboration of the predictive model
During a seven months period ended on December 2008
a total of 2147 live births took place in our institution
but only 1708 healthy newborn infants were considered
for the study because 439 did not meet criteria for
enrolment. Exclusion criteria were prematurity, congeni-
tal anomalies, Rh or major ABO isoimmunization
indexed by a positive direct antiglobulin test, or the
need of intensive care. Infants presenting with delayed
meconium emission (> 24 hours), hypoglycemia,
hypothermia, cephalohaematoma, cutaneous bruising,
hemorrhagic disease of the newborn (vitamin K defi-
ciency), urinary tract infection, and suspected clinical
sepsis were also excluded. All included babies were full
term (gestational age ≥ 37 weeks), appropriate for gesta-
tional age (birth weight > 10
th centile), delivered by
vaginal birth or caesarean section after uneventful preg-
nancy, without asphyxia (Apgar score ≥ 7a t1a n d5
minutes). No drugs were administered to the infants,
except for 1 mg vitamin K (Konakion, Roche Labora-
tories, Nutley, NJ) intramuscularly soon after birth.
Feeding was started at 1 hour of life, followed by breast-
feeding or bottle-feeding every 3 hours in case of low
breast milk intake. No prophylactic intervention for
hyperbilirubinemia was employed. Environmental light-
ing was constant during the study period. The infants
were eligible for discharge 72 hours after birth in case
of vaginal delivery and 96 hours in case of caesarean
section. After obtaining parental informed consent, TSB
was measured on capillary blood (OHC Photo-Ict-
ometer, model IV, O’Hare & Co., Ltd., Tokyo, Japan) at
12 hours of life and then every 12-24 hours during the
first three day of life or when clinically indicated. New-
born babies with TSB values > 15 mg/dl were dis-
charged after a TSB decrease at two consecutive
samples. In these infants direct acting bilirubin measure-
ment was also performed.
Table 1 shows the clinical characteristics of the infants
considered to perform hour-specific nomogram. Mean
gestational age was 39.3 ± 1.3 weeks (range: 37-42) and
mean birth weight was 3.302 ± 432 grams (range: 2580-
4720); the male to female ratio was close to one; two
thirds of the infants had been vaginally delivered and
the majority was totally breastfed. Eighty nine neonates
(5.2%) had TSB value > 15 mg/dl, while only 51 (3.0%)
exceeded the value of 17 mg/dl. For newborn infants
treated with phototherapy according to the American
Academy of Pediatrics [20] we considered only pretreat-
ment values. The highest TSB values showed a Gaussian
distribution. Three hundred fifty (20.5%) infants reached
their highest value between 24 and 48 hours of life, 837
(49.0%) had the highest TSB value between 49 and 72
hours, while 364 (21.3%) and 157 (9.2%) newborn
infants reached their highest value from 73 to 96 hours
and from 97 to 120 hours of life, respectively. The cor-
relation between the TSB value obtained at single hourly
determination during the first 96 hours of life and the
highest absolute value was calculated using the linear
regression analysis. No significant correlation between
the TSB value in the first 12-24 hours of life and the
highest TSB level was observed. On the contrary, there
was a significant correlation between TSB values mea-
sured from 25 hours onwards and highest TSB levels (p
< 0.001). Data were analyzed by using SPSS 15.0 for
Table 1 Clinical characteristics of newborn infants
studied to perform hour-specific nomogram.
Variables Neonates (1708)
Gestational age (wks)
37 234 (13.7)
38 325 (19.0)
39 364 (21.3)
40 453 (26.5)
41 284 (16.6)
42 48 (2.8)
Birth weight (g)
≤3000 350 (20.5)
3001-3499 697 (40.8)
3501-3999 521 (30.5)
≥ 4000 140 (8.2)
Male/Female 943/765 (55.2/44.8)
Mode of delivery
Vaginal 1085 (63.5)
Cesarean section 542 (31.7)
Vacuum extractor 81 (4.8)
Feeding
Exclusive breast feeding 1304 (76.3)
Breast + bottle feeding 143 (8.4)
Bottle feeding 261 (15.3)
Values expressed as number (%)
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Page 2 of 8Windows (SPSS, Chicago, IL). TSB percentiles for each
designated time were calculated, and these data were
used for the design of an hour specific nomogram
(Table 2) with Microsoft Excel (Microsoft, Redmond,
WA).
Phase two - Prospective application of the predictive
model
I np h a s et w ot h ep r e d i c t i v ea b i l i t yo fa nh o u r l yT S B
value measured between 24 to 96 hours was assessed
using percentile-based hour-specific nomogram and
based on the frequency of any subsequent significant
severe hyperbilirubinemia defined as TSB value > 17
mg/dL, or as need for phototherapy treatment according
to AAP guidelines [20].
During a 10-month period, ending in December 2009,
a multicenter prospective study was conducted in five
neonatal units of Rome. The study involved 2167 neo-
nates with gestational age > 34 weeks, based on post-
menstrual date confirmed by clinical assessment. Infants
with congenital anomalies and those requiring neonatal
intensive care were excluded from the study. All infants
received 0.5 - 1 mg of vitamin K intramuscularly or
orally soon after their birth. No prophylactic interven-
tion for hyperbilirubinaemia was employed. The mea-
surement of TSB was performed in jaundiced newborn
infants and/or just before the discharge from the hospi-
tal. In all newborn babies blood samples (75 μl) for the
measurements of TSB were collected by heel stick punc-
ture. Capillary tubes were protected from light exposure
and after centrifugation they were assayed with the
direct spectrophotometer (Microbilimeter Dual Beam
Plus model 11144A73G, Ginevri, Rome, Italy) within 30
minutes. Studied infants were never discharged before
72 hours of age independently from the mode of deliv-
ery. All newborn babies with a predischarge TSB value
>7 5
th percentile of our nomogram were discharged
only after two consecutive decreasing TSB values, 12
hours apart, making us able to identify the maximum
TSB level. Newborn infants with pre-discharge TcB level
between the 50
th and the 75
th percentile were dis-
charged and controlled 48 hours later for hyperbilirubi-
naemia. Parents of infants with TSB < 50
th percentile
were counseled to return to the hospital within 5 days
after discharge, or even earlier if persistent jaundice was
observed. The decision to use phototherapy was made
by the attending neonatologist according to AAP guide-
lines [20]. For babies exposed to phototherapy we con-
sidered only pre-treatment measurements. All perinatal
data were recorded in a single database for each site
with a selected log of any event occurring during the
study period. Care was taken that the same clinical pro-
tocol study, method for sample collection and strategies
for patient recruitment were prospectively maintained,
so that the data from each unit could be pooled.
In our percentile-based hour-specific nomogram the
TSB measurements were plotted on our nomogram
separately by two researchers (CR and GB) after com-
pletion of the study. Statistical analysis was performed
using Student’s t-test for continuous predictors and
Fisher’s test for categorical data. We calculated the sen-
sitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) plotting TSB data in the
50
th,7 5
th and 90
th percentile of our TSB nomogram.
Special care was given to evaluate the ability of our
nomogram in predicting infants without risk for subse-
quent severe hyperbilirubinemia. Receiver operating
characteristic (ROC) curve analysis was performed with
SPSS software, which was used to assess the predictive
ability of our TSB nomogram.
Results
Table 3 shows the baseline characteristics of the study
population. 184 neonates (8,5%) were late preterm and
there was a slight prevalence of males. The mean ± SD
Table 2 Values of TSB corresponding at the 50
th,7 5
th
and 90
th percentile of the hour-specific nomogram
elaborated in our population.
Hrs 50
th 75
th 90
th Hrs 50
th 75
th 90
th Hrs 50
th 75
th 90
th
24 6.1 7.5 8.9 49 9.0 10.3 11.9 73 10.0 11.7 13.2
25 6.2 7.7 9.1 50 9.1 10.4 12.0 74 10.0 11.8 13.3
26 6.4 7.8 9.2 51 9.1 10.4 12.1 75 10.1 11.8 13.3
27 6.5 8.0 9.3 52 9.2 10.5 12.2 76 10.1 11.8 13.4
28 6.7 8.2 9.5 53 9.2 10.6 12.3 77 10.2 11.9 13.4
29 6.8 8.3 9.6 54 9.3 10.7 12.4 78 10.2 11.9 13.5
30 7.0 8.5 9.7 55 9.3 10.8 12.5 79 10.3 12.0 13.5
31 7.2 8.6 9.9 56 9.3 10.8 12.5 80 10.3 12.1 13.6
32 7.3 8.7 10.1 57 9.3 10.9 12.6 81 10.4 12.1 13.7
33 7.5 8.9 10.2 58 9.4 10.9 12.7 82 10.5 12.2 13.7
34 7.7 9.0 10.5 59 9.4 11.0 12.8 83 10.6 12.3 13.8
35 7.9 9.1 10.6 60 9.5 11.0 12.9 84 10.6 12.4 13.8
36 8.0 9.2 10.8 61 9.5 11.1 12.9 85 10.6 12.4 13.9
37 8.1 9.3 10.8 62 9.5 11.1 12.9 86 10.7 12.5 14.0
38 8.2 9.4 10.9 63 9.5 11.2 12.9 87 10.7 12.5 14.1
39 8.3 9.5 10.9 64 9.6 11.2 13.0 88 10.7 12.5 14.2
40 8.4 9.6 11.0 65 9.6 11.3 13.0 89 10.8 12.6 14.3
41 8.5 9.7 11.1 66 9.6 11.3 13.0 90 10.8 12.6 14.4
42 8.6 9.8 11.1 67 9.6 11.4 13.0 91 10.9 12.7 14.5
43 8.7 9.9 11.2 68 9.6 11.4 13.1 92 11.0 12.9 14.6
44 8.7 9.9 11.3 69 9.7 11.5 13.1 93 11.2 13.0 14.7
45 8.8 10.0 11.5 70 9.8 11.6 13.1 94 11.3 13.2 14.8
46 8.9 10.1 11.6 71 9.8 11.7 13.2 95 11.4 13.4 14.9
47 8.9 10.2 11.7 72 9.9 11.7 13.2 96 11.5 13.5 15.0
48 9.0 10.2 11.8
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5090) and for gestational age 38.9 ± 1.5 weeks (range
35-42). Babies were predominantly Caucasian (90.1%)
and uniformly coming from caesarean section or vaginal
delivery. Exclusive breast feeding was prevalent, but
39.1% of babies received also bottle feeding during their
hospital stay. The mean age for TSB sampling was 63 ±
21 SD hours and the mean TSB value was 9.4 ± 0.6 mg/
dL. Significant hyperbilirubinaemia, defined as TSB
value > 17 mg/dL or as need for phototherapy was diag-
nosed in 55 newborns (2.5%): 46 neonates required
phototherapy while 9 newborn babies reached a TSB
value greater than 17 mg/dL but were not treated.
Direct acting bilirubin was normal in all infants with
TSB > 15 mg/dL. No exchange transfusion was per-
formed and no case of significant hyperbilirubinaemia
was documented after discharge.
Sensitivity, specificity, PPV and NPV of percentiles of
our TSB nomogram in predicting significant hypebiliru-
binaemia are listed in table 4. Using the 75
th percentile
100% of sensitivity was reached only after 72 hours,
while three false negative results were obtained between
24-48 hours and one false negative result has been
observed between 49-72 hours. The use of the 50
th per-
centile predicted all newborn without subsequent signifi-
cant hyperbilirubinaemia after 48 hours while there was
only one false negative result between 24-48 hours.
Figure 1 depicts the ROC curves during different
hours of age. The AUC measures the accuracy of the
50
th, the 75
th and the 90
th percentile in predicting signif-
icant hyperbilirubinaemia. AUC increased gradually with
hours of age (0.869 for 24-48 h; 0.948 for 49-72 h; 0.969
for 73-96 h). Figure 2 shows the comparison of the
ROC curves during different hours of age.
Bhutani hour specific nomogram was applied in our
study population (table 5).
W ef o u n dn od i f f e r e n c eb e t w e e nt h ep r e d i c t i v ea b i l -
ity of our 50
th percentile and that of the 40
th percentile
of Bhutani (table 6). The sensitivity of our 75
th percen-
tile was greater than the one obtained with the 75
th
percentile of Bhutani, and this difference was more
evident between 49 and 72 hours (1 vs. 6 false negative
results).
Table 3 Baseline characteristics of the study population
included in phase 2.
Variables Neonates (2167)
Gestational age (wks) 38.9 ± 1.5
> 37 wks 1983 (91.5)
35 - 36 wks 184 (8.5)
Birth weight (g) 3237 ± 471
Small for gestational age 115 (5.3)
Male 1137 (52.5)
Race
White 1952 (90.1)
Asian 106 (4.9)
Black African 55 (2.5)
Hispanic 54 (2.5)
Mode of delivery
Vaginal 1159 (53.5)
Cesarean section 953 (44)
Vacuum extractor 55 (2.5)
Apgar score
< 7 at 1’ 53 (2.4)
< 7 at 5’ 0
Feeding
Exclusive breast feeding 1267 (58.5)
Breast + bottle feeding 848 (39.1)
Bottle feeding 52 (2.4)
Weight loss > 10% 127 (5.9)
Age at TSB (h.) 63 ± 21
TSB value (mg/dL) 9.4 ± 0.6
Significant hyperbilirubinemia 55 (2.5)
Required phototherapy 46 (2.1)
TSB > 17 mg/dL 9 (0.4)
Values expressed as mean ± SD or number (%)
Table 4 Ability of TSB measurements over the 50
th, the
75
th and the 90
th percentile of TSB nomogram to predict
significant hyperbilirubinaemia, for designated time
periods.
Hours of age TP
(n)
FN
(n)
TN
(n)
FP
(n)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
24 to 48
hours
<5 0
th
percentile
24 1 357 263 96.0 57.6 8.4 99.7
<7 5
th
percentile
22 3 479 141 88.0 77.3 13.5 99.4
<9 0
th
percentile
12 13 576 44 48.0 92.9 21.4 97.8
49 to 72
hours
<5 0
th
percentile
23 0 657 368 100 64.1 5.9 100
<7 5
th
percentile
22 1 860 165 95.7 83.9 11.8 99.9
<9 0
th
percentile
17 6 975 50 73.9 95.1 25.4 99.4
73 to 96
hours
<5 0
th
percentile
7 0 322 145 100 69.0 4.6 100
<7 5
th
percentile
7 0 409 58 100 87.6 10.8 100
<9 0
th
percentile
6 1 446 21 85.7 95.5 22.2 99.8
TP True Positive; FN False Negative; TN True negative; FP False Positive; PPV
Positive Predictive Value; NPV Negative Predictive Value
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Early discharge is making the jaundice management
quite difficult, since hyperbilirubinaemia is one of the
main reasons for hospital readmission [1,4,5,19,20].
Recent reports suggest an increased occurrence of ker-
nicterus in otherwise healthy newborns in North Amer-
ica, Western Europe and less developed part of the
world [8,21-25]. In its 2004 guidelines, the AAP recom-
mended every newborn be assessed for risk of severe
hyperbilirubinaemia before hospital discharge. Two
methods have been validated: the hour specific bilirubin
measurements (using serum or transcutaneous determi-
nations) and the jaundice clinical risk factor assessment.
These methods can be used individually or jointly for a
pre-discharge risk assessment for subsequent severe
hyperbilirubinaemia. The evaluation of jaundice is now
facilitated by the availability of different nomogram for
b o t hs e r u m[ 2 6 ]a n dt r a n s c u t a n e o u sb i l i r u b i n
[16,27-31]. Although there is good evidence that TcB
provides excellent estimates of the TSB level, TcB
should be used more as a screening tool in order to
reduce the number of TSB measurements needed in the
nursery than as a substitute of TSB [32,33]. Bhutani and
colleagues demonstrated a strong relationship between
the hour specific TSB level and the risk of subsequent
hyperbilirubinaemia [26], but concerns regarding the use
of pre-discharge TSB values were expressed as a conse-
quence of false negative results [17]. Such false negative
results have been described but their exact frequency is
unknown. Two studies of infants readmitted for hyper-
bilirubinaemia showed that 2.7% to 3.6% of babies had a
pre-discharge bilirubin level in the low-risk zone (< 40
th
Figure 1 ROC curves during different hours of age: A) 24-48 h; B) 49-72 h; C) 73-96 h; D) 24-96 h. (AUC area under the curve).
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low-intermediate risk zone (40-75
th percentile) so show-
ing a significant risk of false negative results [18,34].
The rate of false negative and the different performances
of Bhutani nomogram as a predictive tool can be
explained by racial, genetic and environmental factors
that affected the course of neonatal hyperbilirubinaemia.
A nomogram cannot perform well in every setting if the
background between the published and the tested popu-
lation is too much different. Moreover, predictive tools
should be developed in one sample and validated in
another one [35]. The use of Bhutani nomogram as a
screening tool has been questioned because of concerns
regarding its reliability on different population and some
methodological flaw of the study from which it was
developed (i.e. follow-up bilirubin levels not performed
in more than 75% of study participants, and the lack of
validation in an independent patient sample)[17].
Bhutani’s nomogram was generated in a retrospective
study including infants from a single urban Pennsylvania
hospital, so the demographic, racial, genetic and envir-
onmental features of that population may not adequately
represent other newborn populations.
To reach the aim of our study we previously devel-
oped our hour-specific percentile based nomogram
using serial measurements of TSB in a cohort of healthy
full term neonates. In the second phase we verified pro-
spectively its predictive ability to identify newborn at
risk for significant hyperbilirubinaemia (defined as TSB
> 17 mg/dL or need for phototherapy) in a multicenter
study involving a large neonatal population. The
sensitivity of the 50
th percentile was 100% between 49
and 96 hours, while it was affected by one false negative
result before 48 hours of age. Using the 75
th percentile
as risk discriminator we obtained 88% of sensitivity
between 24 and 48 hours (3 false negative results) and
Figure 2 Comparison of the ROC curves during different hours of age.
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negative result). The false negative between 49 and 72
hours was a preterm infant who had his TSB measure-
ment at 70 hours of age and subsequently needed
phototherapy because he reached a TSB value of 16 mg/
dL. This observation suggests that a risk assessment
strategy combining the pre-discharge bilirubin risk zone
and some clinical factor (such as gestational age) could
have a better overall predictive accuracy than a strategy
using pre-discharge bilirubin risk zone by itself [36-39].
In a subsequent analysis we plotted TSB measure-
ments of our study population on Bhutani hour specific
nomogram and we found that the sensitivity and the
specificity of our 50
th percentile were the same as the
40
th percentile of Bhutani. Instead our 75
th percentile
performed better than the 75
th percentile of Bhutani
(sensitivity 92.7% vs. 80%) especially between 49 and 72
hours of age (sensitivity 95.7% vs. 73.9%).
The strengths of our study are the large sample size,
well representing the demographic characteristics of Ita-
lian neonatal population, the high follow-up rate, and its
robust design. It is also noteworthy that it is a prospec-
tive observational study in which enrolled babies were
studied during their hospital stay, thus avoiding sam-
pling bias. All newborns referred to their birth hospital
for clinical follow up after discharge, and no readmis-
sions because of hyperbilirubinaemia were noticed. Our
study has some limitations: firstly, the incidence of sig-
nificant hyperbilirubinaemia is low; secondly it is not a
population based study but the newborns were enrolled
according to the clinical practice of each neonatal unit.
Conclusion
Our percentile based TSB nomogram is a useful tool for
predicting infants without subsequent severe hyperbilir-
ubinaemia before discharge. There is a notable differ-
ence in the false positive rate with the Bhutani’s
nomogram, especially between 49 and 72 hours of age.
It has to be emphasized that the use of pre-discharge
bilirubin screening alone may falsely reassure physicians
about a safe early discharge of the mother-neonate pair.
Bilirubin level should be assessed together with clinical
risk factors (such as gestational age, exclusive breast-
feeding, east asian race, cephalhematoma, significant
bruising or previous sibling with jaundice) to determine
infant risk for subsequent severe hyperbilirubinaemia,
thus ensuring an appropriate follow up.
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Table 5 Ability of TSB measurements over the 40
th and
75
th percentile of Buthani nomogram to predict
significant hyperbilirubinaemia, for designated time
periods.
Hours of
age
TP
(n)
FN
(n)
TN
(n)
FP
(n)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
24 to 48
hours
<4 0
th
percentile
25 0 238 382 100.0 38.4 6.1 100.0
<7 5
th
percentile
21 4 447 173 84.0 72.1 10.8 99.1
49 to 72
hours
<4 0
th
percentile
22 1 732 293 95.7 71.4 7.0 99.9
<7 5
th
percentile
17 6 963 62 73.9 94.0 21.5 99.4
73 to 96
hours
<4 0
th
percentile
7 0 374 93 100 80.1 7.0 100
<7 5
th
percentile
6 1 451 16 85.7 96.6 27.3 99.8
Table 6 Comparison between the predictive ability of our percentiles and those of Buthani.
Hours of age TP
(n)
FN
(n)
TN
(n)
FP
(n)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
24 to 96 hours
<4 0
th percentile of Buthani nomogran 54 1 1344 768 98.2 63.6 6.6 99.9
<5 0
th percentile of our nomogram 54 1 1336 776 98.2 63.3 6.5 99.9
<7 5
th percentile of Buthani nomogram 44 11 1861 251 80.0 88.1 14.9 99.4
<7 5
th percentile of our nomogram 51 4 1748 364 92.7 82.8 12.3 99.8
TP True Positive; FN False Negative; TN True negative; FP False Positive; PPV Positive Predictive Value; NPV Negative Predictive Value
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